IP Library Granted Patent US 9,670,525
Granted Patent B2
US 9,670,525 · App. 14/420,925 · Granted Jun 6, 2017

Method for measuring cholesterol in high-density lipoprotein

Inventors: Rie Utsugi (Sunto-gun, JP); Yuki Katayama (Sunto-gun, JP)
Assignee: KYOWA MEDEX CO., LTD.
C12Q1/60G01N2333/904G01N2333/918
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,670,525
App. No.
14/420,925
Granted
Jun 6, 2017
Kind
B2
Abstract

Provided is a method for measuring cholesterol in high-density lipoprotein (HDL) simply and accurately. A method for measuring cholesterol in high-density lipoprotein in a specimen, comprising reacting the specimen with i) a cholesterol ester hydrolase and a cholesterol oxidase, or ii) a cholesterol ester hydrolase, an oxidized coenzyme, and a cholesterol dehydrogenase, in an aqueous medium comprising at least one substance selected from the group consisting of pyridinium salts and quaternary ammonium salts each having a specific structure, and a polyanion to form hydrogen peroxide or reduced coenzyme and measuring the formed hydrogen peroxide or reduced coenzyme.

Claims (41)

1. A method for measuring cholesterol in high-density lipoprotein in a specimen, comprising

(1) reacting the specimen with i) a cholesterol ester hydrolase and a cholesterol oxidase, or ii) a cholesterol ester hydrolase, an oxidized coenzyme, and a cholesterol dehydrogenase, in an aqueous medium comprising a polyanion, and at least one substance selected from the group consisting of a substance represented by formula (I):

wherein R 1 represents a substituted or unsubstituted alkyl or alkenyl having 8 to 14 carbon atoms; R a represents a hydrogen atom, a substituted or unsubstituted alkyl, or a substituted or unsubstituted alkenyl; n represents an integer of 1 to 5; and X − represents a monovalent anion, and a substance represented by formula (II):

wherein R 2 represents a substituted or unsubstituted alkyl or alkenyl having 6 to 30 carbon atoms; R 3 represents a substituted or unsubstituted alkyl having 1 to 6 carbon atoms or alkenyl having 2 to 6 carbon atoms; R 4 represents a hydrogen atom, substituted or unsubstituted aryl, or substituted or unsubstituted alkyl; and Y − represents a monovalent anion, to form hydrogen peroxide or a reduced coenzyme;

(2) measuring the formed hydrogen peroxide or reduced coenzyme; and

(3) calculating the concentration of HDL cholesterol in the specimen from the value measured in (2) and a previously-prepared calibration curve showing the relationship between HDL cholesterol concentrations and measured values of hydrogen peroxide or reduced coenzyme.

2. The method according to claim 1 , wherein the aqueous medium further comprises albumin.

3. The method according to claim 2 , wherein the polyanion is dextran sulfate or a salt thereof.

4. The method according to claim 1 , wherein the polyanion is dextran sulfate or a salt thereof.

5. A reagent for measuring cholesterol in high-density lipoprotein, comprising a polyanion, a cholesterol ester hydrolase, a cholesterol oxidase, a reagent for measuring hydrogen peroxide, and at least one substance selected from the group consisting of a substance represented by formula (I):

wherein R 1 represents a substituted or unsubstituted alkyl or alkenyl having 8 to 14 carbon atoms; R a represents a hydrogen atom, a substituted or unsubstituted alkyl, or a substituted or unsubstituted alkenyl; n represents an integer of 1 to 5; and X − represents a monovalent anion, and a substance represented by formula (II):

wherein R 2 represents a substituted or unsubstituted alkyl or alkenyl having 6 to 30 carbon atoms; R 3 represents a substituted or unsubstituted alkyl having 1 to 6 carbon atoms or alkenyl having 2 to 6 carbon atoms; R 4 represents a hydrogen atom, a substituted or unsubstituted aryl, or a substituted or unsubstituted alkyl; and Y − represents a monovalent anion.

6. The reagent according to claim 5 , further comprising albumin.

7. The reagent according to claim 6 , wherein the polyanion is dextran sulfate or a salt thereof.

8. The reagent according to claim 5 , wherein the polyanion is dextran sulfate or a salt thereof.

9. A reagent for measuring cholesterol in high-density lipoprotein, comprising a polyanion, a cholesterol ester hydrolase, a cholesterol dehydrogenase, an oxidized coenzyme, and at least one substance selected from the group consisting of a substance represented by formula (I):

wherein R 1 represents a substituted or unsubstituted alkyl or alkenyl having 8 to 14 carbon atoms; R a represents a hydrogen atom, a substituted or unsubstituted alkyl, or a substituted or unsubstituted alkenyl; n represents an integer of 1 to 5; and X − represents a monovalent anion, and a substance represented by formula (II):

wherein R 2 represents a substituted or unsubstituted alkyl or alkenyl having 6 to 30 carbon atoms; R 3 represents a substituted or unsubstituted alkyl having 1 to 6 carbon atoms or alkenyl having 2 to 6 carbon atoms; R 4 represents a hydrogen atom, a substituted or unsubstituted aryl, or a substituted or unsubstituted alkyl; and Y − represents a monovalent anion.

10. The reagent according to claim 9 , further comprising a reagent for measuring a reduced coenzyme.

11. The reagent according to claim 9 , further comprising albumin.

12. The reagent according to claim 11 , wherein the polyanion is dextran sulfate or a salt thereof.

13. The reagent according to claim 9 , wherein the polyanion is dextran sulfate or a salt thereof.

14. The reagent according to claim 10 , further comprising albumin.

15. The reagent according to claim 14 , wherein the polyanion is dextran sulfate or a salt thereof.

16. The reagent according to claim 10 , wherein the polyanion is dextran sulfate or a salt thereof.

17. A kit for measuring cholesterol in high-density lipoprotein comprising a first reagent and a second reagent, wherein a polyanion, and at least one substance selected from the group consisting of a substance represented by formula (I):

wherein R 1 represents a substituted or unsubstituted alkyl or alkenyl having 8 to 14 carbon atoms; R a represents a hydrogen atom, a substituted or unsubstituted alkyl, or a substituted or unsubstituted alkenyl; n represents an integer of 1 to 5; and X − represents a monovalent anion, and a substance represented by formula (II):

wherein R 2 represents a substituted or unsubstituted alkyl or alkenyl having 6 to 30 carbon atoms; R 3 represents a substituted or unsubstituted alkyl having 1 to 6 carbon atoms or alkenyl having 2 to 6 carbon atoms; R 4 represents a hydrogen atom, a substituted or unsubstituted aryl, or a substituted or unsubstituted alkyl; and Y − represents a monovalent anion are comprised in the first reagent, a cholesterol oxidase is comprised in the second reagent, a reagent for measuring hydrogen peroxide is comprised in either the first or second reagent, or in both of the first and second reagents, and a cholesterol ester hydrolase is comprised in either the first or second reagent, or in both of the first and second reagents.

18. The kit according to claim 17 , further comprising albumin in either the first or second reagent, or in both of the first and second reagents.

19. The kit according to claim 17 , wherein the polyanion is dextran sulfate or a salt thereof.

20. The kit according to claim 18 , wherein the polyanion is dextran sulfate or a salt thereof.

21. A kit for measuring cholesterol in high-density lipoprotein comprising a first reagent and a second reagent, wherein a polyanion, and at least one substance selected from the group consisting of a substance represented by formula (I):

wherein R 1 represents a substituted or unsubstituted alkyl or alkenyl having 8 to 14 carbon atoms; R a represents a hydrogen atom, a substituted or unsubstituted alkyl, or a substituted or unsubstituted alkenyl; n represents an integer of 1 to 5; and X − represents a monovalent anion, and a substance represented by formula (II):

wherein R 2 represents a substituted or unsubstituted alkyl or alkenyl having 6 to 30 carbon atoms; R 3 represents a substituted or unsubstituted alkyl having 1 to 6 carbon atoms or alkenyl having 2 to 6 carbon atoms; R 4 represents a hydrogen atom, a substituted or unsubstituted aryl, or a substituted or unsubstituted alkyl; and Y − represents a monovalent anion are comprised in the first reagent, a cholesterol dehydrogenase is comprised in the second reagent, an oxidized coenzyme is comprised in either the first or second reagent, or in both of the first and second reagents, and a cholesterol ester hydrolase is comprised in either the first or second reagent, or in both of the first and second reagents.

22. The kit according to claim 21 , further comprising a reagent for measuring a reduced coenzyme in either the first or second reagent, or in both of the first and second reagents.

23. The kit according to claim 21 , further comprising albumin in either the first or second reagent, or in both of the first and second reagents.

24. The kit according to claim 23 , wherein the polyanion is dextran sulfate or a salt thereof.

25. The kit according to claim 22 , further comprising albumin in either the first or second reagent, or in both of the first and second reagents.

26. The kit according to claim 25 , wherein the polyanion is dextran sulfate or a salt thereof.

27. The kit according to claim 21 , wherein the polyanion is dextran sulfate or a salt thereof.

28. The kit according to claim 22 , wherein the polyanion is dextran sulfate or a salt thereof.

Assignments (4)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2015
From: UTSUGI, RIE; KATAYAMA, YUKI
To: KYOWA MEDEX CO., LTD.
Reel/Frame 034936/0154 →
Priority Claims (1)
JP 2012-191144 · Aug 31, 2012 · national
Continuity (1)
Related Publication 20150232914A1 · Aug 20, 2015